Charles Nicolette - CSO and Vice President R&D, Argos Therapeutics Inc

As of April 25, 2018


What is Charles Nicolette's Net Worth?

The current estimated net worth of Argos Therapeutics Inc's CSO and Vice President R&D, Charles Nicolette, is estimated to be about $31.56K . Charles Nicolette owns about 399,990 units of Argos Therapeutics Inc common stock. In the last 4 years at Argos Therapeutics Inc, Charles Nicolette has sold an estimated value of $31.56K worth.

What is Charles Nicolette's Past Insider Trading?

Charles Nicolette's largest purchase order was 5,000 units , worth over $32.25K on August 27, 2015. Charles Nicolette's largest sale order was 100,250 units , worth over $16.5K on January 12, 2018. In total, Charles Nicolette has made about 11 transactions over 4 years of their time at Argos Therapeutics Inc. Charles Nicolette usually trades in January, with the busiest year in 2018.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What was Charles Nicolette's Salary in 2016?

As CSO and Vice President R&D of Argos Therapeutics Inc, Charles Nicolette has a total base salary of $325,000 . Charles Nicolette received compensation valued at about $1,186,469 in 2016 after becoming CSO and Vice President R&D. The vast majority of their compensation came in the form of a bonus of $121,875 , option awards of $720,925 , and other compensation of $18,669 .

What is Charles Nicolette's' Mailing Address?

  • Mailing address is Argos Therapeutics, Inc. 4233 Technology Drive Durham NC 27704 NC

Argos Therapeutics Inc Executive Compensation

Name
Year
Salary
Bonus
Option Awards
Other Compensation
Total
Jeffrey D. Abbey 2016 $450,000 $356,500 $1,029,892 $26,477 $1,862,869
Jeffrey D. Abbey 2015 $450,000 $202,500 $714,502 $14,861 $1,381,863
Charles A Nicolette, Ph.D. 2016 $325,000 $121,875 $720,925 $18,669 $1,186,469
Charles A Nicolette, Ph.D. 2015 $325,000 $108,875 $446,564 $17,217 $897,656
Lee F. Allen, M.D., Ph.D. 2016 $407,292 $389,375 $1,016,592 $70,120 $1,883,379
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1105533/000117184317003980/def14a_070617.htm

What are Argos Therapeutics Inc's Past Insider Trades?

Argos Therapeutics Inc's most recent insider trade came on January 12, 2018 by Lori R Harrelson who sold 64,329 units worth $10.59K . In the last 4 years, insiders at Argos Therapeutics Inc have sold an estimated value of $79.34M and bought an estimated value of $13.75M worth of shares. Insider trading is most common in January, with the busiest year in 2016. The most active traders at the company are Jeffrey Abbey, Chief Executive Officer,  Pharmstandard Co Stock Joint,  and Sa International Pharmstandard .

ARGOS THERAPEUTICS INC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1